Concepts (50)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Rheumatoid | 4 | 2015 | 172 | 0.450 |
Why?
|
| Antirheumatic Agents | 2 | 2015 | 60 | 0.250 |
Why?
|
| Biological Products | 2 | 2015 | 166 | 0.210 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2011 | 211 | 0.190 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1996 | 11 | 0.130 |
Why?
|
| Retroviridae Infections | 1 | 1996 | 48 | 0.130 |
Why?
|
| Rheumatology | 1 | 2015 | 35 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2015 | 359 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 64 | 0.090 |
Why?
|
| Interferon-alpha | 1 | 2011 | 214 | 0.090 |
Why?
|
| Immunotherapy | 1 | 1996 | 703 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2011 | 275 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2011 | 1382 | 0.060 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 440 | 0.050 |
Why?
|
| Risk Factors | 3 | 2015 | 5580 | 0.040 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 1996 | 3 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1996 | 42 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1996 | 182 | 0.030 |
Why?
|
| Drug Eruptions | 1 | 1996 | 32 | 0.030 |
Why?
|
| Family Health | 1 | 1996 | 162 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 1996 | 179 | 0.030 |
Why?
|
| Risk-Taking | 1 | 1996 | 157 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 1996 | 344 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 1996 | 151 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 1996 | 694 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 1015 | 0.030 |
Why?
|
| Consensus | 1 | 2015 | 371 | 0.030 |
Why?
|
| Sex Factors | 1 | 1996 | 1074 | 0.030 |
Why?
|
| Patient Selection | 1 | 2015 | 682 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 1996 | 1726 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2015 | 591 | 0.020 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2011 | 11 | 0.020 |
Why?
|
| Age Factors | 1 | 1996 | 1871 | 0.020 |
Why?
|
| Humans | 5 | 2015 | 90568 | 0.020 |
Why?
|
| Alleles | 1 | 2011 | 1138 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 1996 | 2667 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2505 | 0.020 |
Why?
|
| Middle Aged | 2 | 1996 | 26327 | 0.020 |
Why?
|
| DNA | 1 | 2011 | 1314 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 1996 | 6812 | 0.020 |
Why?
|
| Adolescent | 1 | 1996 | 9353 | 0.010 |
Why?
|
| Male | 2 | 1996 | 42931 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 1996 | 8373 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2424 | 0.010 |
Why?
|
| United States | 1 | 2015 | 7142 | 0.010 |
Why?
|
| Female | 2 | 1996 | 46855 | 0.010 |
Why?
|
| Neoplasms | 1 | 1996 | 3029 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 3426 | 0.010 |
Why?
|
| Aged | 1 | 1996 | 19404 | 0.010 |
Why?
|
| Adult | 1 | 1996 | 26940 | 0.010 |
Why?
|